DNA Brands(DNAX)
$0.000.00 (0.00%)
DNAX
DNA Brands financials statements
$0.00
At close:0.00 (0.00%)
DNA Brands (DNAX) Ratios
19 Followers
DNA Brands Ratios
DNAX's free cash flow for Q3 2023 was $4.33K. For the 2023 fiscal year, DNAX's free cash flow was increased by $0.00 and operating cash flow was $4.33K. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.01 | 0.01 | 0.04 | 0.01 | 0.01 |
| Quick Ratio | 0.01 | 0.01 | 0.04 | 0.01 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.03 | 0.01 | 0.00 |
| Solvency Ratio | -0.10 | -0.05 | -0.12 | -0.46 | -0.07 |
| Operating Cash Flow Ratio | -0.00 | -0.15 | -0.17 | -0.40 | -0.01 |
| Short-Term Operating Cash Flow Coverage | -0.00 | -0.19 | -0.22 | -0.51 | -0.02 |
| Net Current Asset Value | $ -5.12M | $ -2.82M | $ -2.51M | $ -2.69M | $ -2.57M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 11.94 | 8.57 | 1.81 | 2.03 | 40.87 |
| Debt-to-Equity Ratio | -0.63 | -0.85 | -1.35 | -1.28 | -0.79 |
| Debt-to-Capital Ratio | -1.67 | -5.84 | 3.87 | 4.63 | -3.71 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.05 | -0.10 | -0.74 | -0.63 | -0.02 |
| Debt Service Coverage Ratio | -0.08 | -0.15 | -0.15 | -0.58 | -0.09 |
| Interest Coverage Ratio | -0.92 | -11.27 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 5.79 | 1.06 | 0.07 | 2.49 | 21.09 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.42 | 3.80 |
| Net Debt to EBITDA | -12.24 | -6.53 | -6.48 | -1.71 | -11.41 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 99.23% | 0.10% | 0.11% |
| EBIT Margin | 0.00% | 0.00% | -66.18% | -500.16% | -1001.77% |
| EBITDA Margin | 0.00% | 0.00% | -65.31% | -498.77% | -974.10% |
| Operating Profit Margin | 0.00% | 0.00% | -66.18% | -499.57% | -1001.77% |
| Pretax Profit Margin | 0.00% | 0.00% | -66.18% | -499.97% | -1001.77% |
| Net Profit Margin | 0.00% | 0.00% | -66.18% | -499.97% | -1001.77% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | -66.18% | -499.97% | -1001.77% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 209.20% | 110.95% | 100.00% | 100.08% | 100.00% |
| Return on Assets (ROA) | -204.05% | -145.52% | -27.39% | -118.41% | -368.11% |
| Return on Equity (ROE) | 10.69% | 14.50% | 20.38% | 74.34% | 7.10% |
| Return on Capital Employed (ROCE) | 5.11% | 13.07% | 20.38% | 74.28% | 7.10% |
| Return on Invested Capital (ROIC) | 13.64% | 89.44% | -58.53% | -269.94% | 33.43% |
| Return on Tangible Assets | -204.05% | -145.52% | -27.39% | -118.41% | -368.11% |
| Earnings Yield | -99.03% | -18.01% | -1.01% | -145.17% | -189.91% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.03 | 2.31 | 0.17 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 62.49 | 22.88 | 0.80 |
| Asset Turnover | 0.00 | 0.00 | 0.41 | 0.24 | 0.37 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | -0.18 | -0.09 | -0.01 |
| Cash Conversion Cycle | 0.00 | 0.00 | -11135.19 | -158.10 | -2179.04 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 11135.19 | 158.10 | 2179.04 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.21 | -0.06 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.21 | -0.12 |
| Dividend Paid and CapEx Coverage Ratio | -3008.75 | 0.00 | -144832.33 | -273866.00 | -1.23 |
| Capital Expenditure Coverage Ratio | -3008.75 | 0.00 | -144832.33 | -273866.00 | -1.23 |
| Operating Cash Flow Coverage Ratio | -0.00 | -0.19 | -0.22 | -0.51 | -0.02 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | -0.95 | -4.40 | -1.89 |
| Free Cash Flow Yield | -2.28% | -20.24% | -1.44% | -127.74% | -64.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.01 | -5.55 | -99.24 | -0.69 | -0.53 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 65.68 | 3.44 | 5.27 |
| Price-to-Book (P/B) Ratio | -0.11 | -0.80 | -20.22 | -0.51 | -0.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -43.86 | -4.94 | -69.43 | -0.78 | -1.55 |
| Price-to-Operating Cash Flow Ratio | -43.88 | -4.94 | -69.43 | -0.78 | -2.80 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.33 | 0.99 | 0.02 | 0.01 |
| Enterprise Value Multiple | -14.35 | -12.69 | -107.04 | -2.40 | -11.96 |
| Enterprise Value | 3.59M | 4.29M | 32.11M | 2.98M | 2.10M |
| EV to EBITDA | -14.35 | -12.69 | -107.04 | -2.40 | -11.96 |
| EV to Sales | 0.00 | 0.00 | 69.91 | 11.96 | 116.47 |
| EV to Free Cash Flow | -297.95 | -10.18 | -73.91 | -2.72 | -34.13 |
| EV to Operating Cash Flow | -298.07 | -10.18 | -73.91 | -2.72 | -61.78 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.33 | -4.82 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.00 | -0.33 | -4.82 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.05 | 0.03 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.24 | -0.34 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 2.09 | 1.09 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 1.81 | 10.72 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.02 | 1.12 | 1.43 | 0.88 | 0.19 |
Currency in USD
